Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.

Haller JF, Cavallaro P, Hernandez NJ, Dolat L, Soscia SJ, Welti R, Grabowski GA, Fitzgerald ML, Freeman MW.

J Lipid Res. 2014 Mar;55(3):493-503. doi: 10.1194/jlr.M044941. Epub 2013 Nov 30.

2.

Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Moncaster JA, Pineda R, Moir RD, Lu S, Burton MA, Ghosh JG, Ericsson M, Soscia SJ, Mocofanescu A, Folkerth RD, Robb RM, Kuszak JR, Clark JI, Tanzi RE, Hunter DG, Goldstein LE.

PLoS One. 2010 May 20;5(5):e10659. doi: 10.1371/journal.pone.0010659.

3.

The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD.

PLoS One. 2010 Mar 3;5(3):e9505. doi: 10.1371/journal.pone.0009505.

4.

Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain.

Soscia SJ, Tong M, Xu XJ, Cohen AC, Chu J, Wands JR, de la Monte SM.

Cell Mol Life Sci. 2006 Sep;63(17):2039-56.

PMID:
16909201
5.

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM.

J Alzheimers Dis. 2006 Mar;9(1):13-33.

PMID:
16627931
6.

Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.

Soscia SJ, Harrington ME.

Neurosci Lett. 2005 Jan 20;373(3):175-8. Epub 2004 Dec 16.

PMID:
15619538
7.

Supplemental Content

Loading ...
Support Center